Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
18.44
Dollar change
+0.16
Percentage change
0.88
%
CategoryTarget Date / Multi-Asset - Other Asset TypeMulti-Asset - Tactical / Active TagsU.S. Return% 1Y5.31% Shs Outstand Perf Week-4.81%
SponsorSimplify ETF ETF Type Tagsequity Return% 3Y- Total Holdings22 Perf Month-28.17%
Fund Family Bond Type Tagsbonds Return% 5Y- AUM82.08M Perf Quarter-20.08%
Index- Average Maturity Tagsmulti-asset Return% 10Y NAV% Perf Half Y-19.94%
Index Weighting Commodity Type Tagshealthcare Return% SI NAV/sh Perf Year-7.88%
Active/Passive Quant Type Tagsbiotechnology Flows% 1M0.00% 52W Range18.28 - 27.52 Perf YTD-10.80%
Dividend TTM3.29 (17.84%) ESG Type Tagspharmaceutical Flows% 3M2.70% 52W High-33.00% Beta1.01
Dividend Ex-DateSep 25, 2024 Dividend Type Sector/Theme Flows% YTD0.71% 52W Low0.88% ATR (14)0.66
Expense2.51% Structure Type Region Flows% 1Y RSI (14)26.07 Volatility1.40% 1.97%
Option/ShortNo / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.13 Prev Close18.28
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume5.91K Price18.44
SMA20-16.39% SMA50-20.04% SMA200-21.06% Trades Volume750 Change0.88%
Simplify Propel Opportunities ETF seeks to provide long-term growth of capital. The fund is an actively managed exchange-traded fund. The Sub-Adviser concentrates the fund's investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries. The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, and ETFs that primarily invest in the preceding security types. The fund is non-diversified.